Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial

M. K. Han; G. J. Criner; M. T. Dransfield; D. M. G. Halpin; C. E. Jones; S. Kilbride; P. Lange; D. A. Lipson; D. A. Lomas; F. J. Martinez; I. Naya; S. J. Pascoe; R. A. Wise; D. Singh

doi:10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial

M. K. Han, G. J. Criner, M. T. Dransfield, D. M. G. Halpin, C. E. Jones, S. Kilbride, P. Lange, D. A. Lipson, D. A. Lomas, F. J. Martinez, I. Naya, S. J. Pascoe, R. A. Wise, D. Singh

Afdeling for Epidemiologi

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	A102
Tidsskrift	American Journal of Respiratory and Critical Care Medicine
Vol/bind	199
Udgave nummer	A2438
ISSN	1073-449X
DOI	https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438
Status	Udgivet - 2019

Adgang til dokumentet

10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Citationsformater

Han, M. K., Criner, G. J., Dransfield, M. T., Halpin, D. M. G., Jones, C. E., Kilbride, S., Lange, P., Lipson, D. A., Lomas, D. A., Martinez, F. J., Naya, I., Pascoe, S. J., Wise, R. A., & Singh, D. (2019). Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial. American Journal of Respiratory and Critical Care Medicine, 199(A2438), [A102]. https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol : A Prospective Analysis of the IMPACT Trial. / Han, M. K.; Criner, G. J.; Dransfield, M. T.; Halpin, D. M. G.; Jones, C. E.; Kilbride, S.; Lange, P.; Lipson, D. A.; Lomas, D. A.; Martinez, F. J.; Naya, I.; Pascoe, S. J.; Wise, R. A.; Singh, D.

I: American Journal of Respiratory and Critical Care Medicine, Bind 199, Nr. A2438, A102, 2019.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Han, MK, Criner, GJ, Dransfield, MT, Halpin, DMG, Jones, CE, Kilbride, S, Lange, P, Lipson, DA, Lomas, DA, Martinez, FJ, Naya, I, Pascoe, SJ, Wise, RA & Singh, D 2019, 'Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial', American Journal of Respiratory and Critical Care Medicine, bind 199, nr. A2438, A102. https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Han MK, Criner GJ, Dransfield MT, Halpin DMG, Jones CE, Kilbride S et al. Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial. American Journal of Respiratory and Critical Care Medicine. 2019;199(A2438). A102. https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

Han, M. K. ; Criner, G. J. ; Dransfield, M. T. ; Halpin, D. M. G. ; Jones, C. E. ; Kilbride, S. ; Lange, P. ; Lipson, D. A. ; Lomas, D. A. ; Martinez, F. J. ; Naya, I. ; Pascoe, S. J. ; Wise, R. A. ; Singh, D. / Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol : A Prospective Analysis of the IMPACT Trial. I: American Journal of Respiratory and Critical Care Medicine. 2019 ; Bind 199, Nr. A2438.

@article{47ffc183ffb24775a93a359268703cf4,

title = "Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol: A Prospective Analysis of the IMPACT Trial",

author = "Han, {M. K.} and Criner, {G. J.} and Dransfield, {M. T.} and Halpin, {D. M. G.} and Jones, {C. E.} and S. Kilbride and P. Lange and Lipson, {D. A.} and Lomas, {D. A.} and Martinez, {F. J.} and I. Naya and Pascoe, {S. J.} and Wise, {R. A.} and D. Singh",

year = "2019",

doi = "10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438",

language = "English",

volume = "199",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

number = "A2438",

}

TY - ABST

T1 - Preventing Clinically Important Deterioration (CID) of COPD with Single-inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol

T2 - A Prospective Analysis of the IMPACT Trial

AU - Han, M. K.

AU - Criner, G. J.

AU - Dransfield, M. T.

AU - Halpin, D. M. G.

AU - Jones, C. E.

AU - Kilbride, S.

AU - Lange, P.

AU - Lipson, D. A.

AU - Lomas, D. A.

AU - Martinez, F. J.

AU - Naya, I.

AU - Pascoe, S. J.

AU - Wise, R. A.

AU - Singh, D.

PY - 2019

Y1 - 2019

U2 - 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

DO - 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A2438

M3 - Conference abstract in journal

VL - 199

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - A2438

M1 - A102

ER -